Guest Contributor


People:
Dr Daniel Podolsky, Dr Pat Jamieson, Dr Ronald Bond, Dr Ted Hewitt, Dr Thomas Parr, Garold G. Breit, and Marcel Chartrand

Dr Thomas Parr

Guest Contributor
February 7, 2005

Dr Thomas Parr has been appointed chief scientific officer of Targanta Therapeutics Inc (formerly PhageTech Inc), a private biopharmaceutical firm developing new classes of antibiotics based on its work with phage genomics (bacterial viruses). Parr was formerly with Adaptive Therapeutics, VP R&D at Embiosis Pharmaceuticals and senior director of microbiology with Xenogen Corp. He holds a PhD from the Univ of Calgary….


Other News

Dr Pat Jamieson

Marcel Chartrand

Errol Caldwell

Guan Saw






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.